Tokunaga, E., Fujita, A., Takizawa, K., Baba, K., Akiyoshi, S., Nakamura, Y., . . . Ishida, M. (2018). CD44v9 as a poor prognostic factor of triple-negative breast cancer treated with neoadjuvant chemotherapy. Breast Cancer.
Citação norma ChicagoTokunaga, Eriko, et al. "CD44v9 As a Poor Prognostic Factor of Triple-negative Breast Cancer Treated With Neoadjuvant Chemotherapy." Breast Cancer 2018.
MLA CitationTokunaga, Eriko, et al. "CD44v9 As a Poor Prognostic Factor of Triple-negative Breast Cancer Treated With Neoadjuvant Chemotherapy." Breast Cancer 2018.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.